Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × UNKNOWN × Epirubicin × Clear all

Phase

Status

Unknown 5 Recruiting 1 Not yet recruiting 1

Sponsor Class

OTHER 20 INDUSTRY 2 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

pirarubicin 1 pegylated granulocyte colony-stimulating factor 1 Standard of Care 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Platinum 1 Paclitaxel 1 Epirubicin 1 Drug Therapy 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04437160 2020-06-18

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

ChineseAMS

Phase 2 Recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡